The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This podcast is designed to help pathologists and laboratory professionals gain an understanding ... Show More
Apr 10
Annual Meeting Special Episode – Workforce and Recruitment in Pathology
Recorded live at the 2025 ASCP Annual Meeting in Atlanta, this special episode of Inside the Lab brings together a diverse panel—a practicing pathologist, two medical students, and a resident—to explore one of the profession’s most urgent challenges: the pathology workforce short ... Show More
43m 40s
Jan 9
Advances in NSCLC Biomarker Testing
The current landscape of testing for NSCLC is complex, with many new biomarkers emerging rapidly, more points during which testing is possible, and precision drug treatments available on the basis of findings from biomarker testing. While promising for patients, the result of thi ... Show More
49m 49s
Jan 2024
How Can We Reduce Unnecessary Lab Testing?
Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ... Show More
15m 15s
Jun 2025
Advancing Radiology for Early Alzheimer's Detection - Sponsored by Eli Lilly and Company
<p>In this episode, Dr. Ashwin Parihar speaks with Dr. Petrice Cogswell about the radiologist's critical role in diagnosing Alzheimer's disease and how imaging advances are reshaping early detection. They also explore how innovation at scale, platform thinking, and operational al ... Show More
20m 44s
Mar 2024
Ep. 422 Pathology 101: Solid Advice for Percutaneous Biopsies with Dr. Andrew Sholl
In this episode of the BackTable Podcast, host Dr. Chris Beck interviews guest Dr. Andrew Sholl, who demystifies the ins and outs of percutaneous biopsies and their impact on diagnoses. Dr. Scholl is a pathologist at LCMC Health in New Orleans, Louisiana.
Dr. Sholl emphasizes th ... Show More
56m 5s
Jul 2024
Salivary biomarkers: Future clinical and diagnostic applications with Nagihan Bostanci
<p>In the latest episode of the Next Regeneration podcast, hosts Anina and Elena talk to Nagihan Bostanci, the Head of Internationalization in Dentistry and Professor of Inflammation Research in Periodontology at the Karolinska Institute in Stockholm, Sweden. Together they discus ... Show More
32m 9s
Aug 2025
The 2 Minute Medicine® Podcast- AI Roundup 2
In this episode, we start with Doximity’s nationwide launch of a free AI scribe for every U.S. clinician, designed to cut charting time in half and ease burnout, with analysts predicting it could spark a major pricing shake-up in the medical dictation market. Next, we spotlight U ... Show More
7m 49s
May 2022
S1 Episode 1: Avoiding the Cliff: Screening for Early-Stage Multiple Myeloma
Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/964336). The t ... Show More
24m 2s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multicom ... Show More
24m 12s